Table 1 Demographic and baseline characteristics of the study subjects (±S)
All patients | High school or above | Middle school or less | t’ | P | |
|---|---|---|---|---|---|
No. of patients | 133 | 70 | 63 | ||
Age, years | |||||
Mean (SD) | 32.05 ± 8.95 | 32.30 ± 8.67 | 31.78 ± 9.26 | 0.448 (υ = 129) | >0.05 |
Range | 20–57 | 20–56 | 22–57 | ||
Gender, n (%) | |||||
Male | 72 (54.1) | 39 (55.7) | 33 (52.4) | 0.046 (χ 2) | >0.05 |
Drugs | >0.05 | ||||
Atypical | 123 | 64 | 59 | ||
Typical | 10 | 6 | 4 | ||
Course of illness, years | |||||
Mean (SD) | 4.32 ± 6.14 | 4.07 ± 6.37 | 4.6 ± 5.87 | 0.298 | >0.05 |
Range | 0.08–15 | 0.17–13 | 0.08–15 | ||
BPRS scores | |||||
Mean (SD) | 19.87 ± 5.46 | 19.34 ± 5.32 | 20.45 ± 5.61 | 1.17 | >0.05 |
PANSS scores | |||||
Mean (SD) | 44.11 ± 13.1 | 44.06 ± 12.85 | 44.17 ± 13.38 | 0.071 | >0.05 |
CGI-SI | |||||
Mean (SD) | 2.22 ± 0.81 | 2.13 ± 0.84 | 2.32 ± 0.78 | 0.73 | >0.05 |
SSMI 2C | |||||
Mean (SD) | 6.49 ± 0.9 | 7.15 ± 0.98 | 5.75 ± 0.79 | 12.866 | <0.05 |